VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of ...
Sensorium Therapeutics, a biotechnology company developing novel, first-in-class medicines to treat a variety of CNS diseases, announced it presented positive preclinical data on lead programs SENS-01 ...
1 Health Services Research Department, Institute of Psychiatry, London, UK 2 Department of Psychological Medicine, Institute of Psychiatry, London, UK 3 Headache Clinic, King’s College Hospital, ...